Global Hemp Group Appoints Mickey Goldstein as Chief Financial Officer, Appoints Davidson & Company as Auditor
Vancouver, British Columbia--(Newsfile Corp. - October 23, 2026) - Global Hemp Group Inc. (CSE: GHG) (FSE: GHG0) (OTC PINK: GBHPF) ("GHG" or the "Company") is pleased to announce the appointment of Mickey Goldstein, CPA, CA, as Chief Financial Officer, effective immediately. Ms. Goldstein succeeds Christopher Cherry. Ms. Goldstein is Director, Accounting Advisory at Crowe MacKay LLP, where she provides strategic financial and advisory services to priv
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Cannabis
2026-10-23 9:59 AM EDT | Global Hemp Group Inc.
Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery
Carlsbad, California--(Newsfile Corp. - October 22, 2026) - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) ("Aurora Spine" or the "Company"), a developer and manufacturer of minimally invasive spinal implants and interventional pain management technologies, today announced the publication of the REFINE study's 12-month results in the International Journal of Spine Surgery. Published online on October 9, 2026, the article reports on a prospective, obse
2026-10-22 5:56 PM EDT | Aurora Spine Corporation
Envoy Medical Announces Reverse Stock Split
White Bear Lake, Minnesota--(Newsfile Corp. - October 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it will implement a 1-for-10 reverse stock split of its outstanding shares of Class A common stock ("Common Stock"), effective at 12:01 a.m. Eastern Time on October 26, 2026 (the
Biotechnologies, Soins de santé et hôpitaux
2026-10-22 8:30 AM EDT | Envoy Medical, Inc.
CareRx Corporation to Host Third Quarter 2026 Financial Results Conference Call on Thursday, November 5, 2026 at 8:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - October 22, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its third quarter 2026 financial results on Thursday, November 5, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2026 financial results for the period ended September 30, 2026, after market close on Wednesday, November 4, 2026. Telephone Dia
2026-10-22 7:00 AM EDT | CareRx Corporation
TelyRx to Host Third Quarter 2026 Financial Results Conference Call on Friday, November 6, 2026 at 8:30 am ET
Clearwater, Florida--(Newsfile Corp. - October 22, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2026 financial results for the period end
Soins de santé et hôpitaux, Santé
2026-10-22 7:00 AM EDT | TelyRx
The Untold Story of Rick Hansen's Man In Motion World Tour Comes to the Big Screen Across Canada in November
Richmond, British Columbia--(Newsfile Corp. - October 21, 2026) - Man In Motion: The Rick Hansen Story will be a special event release by Cineplex in selected theatres across Canada on November 1 and 3. Tickets are now on sale. The theatrical release follows the film's world premiere at the Toronto International Film Festival (TIFF), where it received an honourable mention for the Best Canadian Feature Film Award, and its hometown premiere at the Vancouver International Film Festival
Divertissement, Soins de santé et hôpitaux, Services d’édition / d’information, Santé
2026-10-21 10:20 AM EDT | Rick Hansen Foundation
Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design
White Bear Lake, Minnesota--(Newsfile Corp. - October 20, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("En
Biotechnologies, Soins de santé et hôpitaux
2026-10-20 8:30 AM EDT | Envoy Medical, Inc.
Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz for $350,000 in Cash
Winter Park, Florida--(Newsfile Corp. - October 20, 2026) - Adia Med, Inc. (OTCQB: ADIA) today announced that its Chief Executive Officer, Larry Powalisz, purchased a 7% economic interest in Adia Labs LLC for $350,000 in cash. Under the completed Membership Interest Purchase Agreement, Powalisz purchased seven membership units at $50,000 per unit. The Company has filed a Current Report on Form 8-K relating to the transaction.
Soins de santé et hôpitaux, Santé
2026-10-20 8:00 AM EDT | Adia Med Inc.
FendX Announces Appointment of Daryl Rebeck to Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - October 20, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection solutions to reduce the spread of harmful pathogens, is pleased to announce the appointment of Mr. Daryl Rebeck to the board of directors, effective October 19, 2026. Mr. Rebeck's appointment follows the resignation of Mr. Pierre Soulard. Mr. Rebeck is a Cana
Technologies, Soins de santé et hôpitaux, Santé
2026-10-20 7:00 AM EDT | FendX Technologies Inc.
ALZAI Health Corp. Posted for Trading On The OTCQB Venture Market
Toronto, Ontario--(Newsfile Corp. - October 20, 2026) - ALZAI Health Corp. (TSXV: ALZI) (OTCQB: ALZIF) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial intelligence-driven disease risk identification solutions, is pleased to announce that its common shares are now quoted for trading on the OTCQB Venture Market ("OTCQB") in the United States under the symbol ALZIF. The OTCQB Venture Market, operated by OTC Markets Group Inc., is a
Technologies, Logiciels, Soins de santé et hôpitaux
2026-10-20 7:00 AM EDT | Alzai Health Corp.
WELL Health Strengthens Privacy and AI Governance Leadership with Appointment of Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory
WELL appoints recognized privacy and healthcare law expert Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory, to lead enterprise privacy, AI governance and healthcare regulatory strategy across the organization. Ms. Starkman previously led the privacy department at Cancer Care Ontario (now part of Ontario Health), co-founded INQ Consulting and was a Partner at INQ Law, advising major Ontario hospitals, pharmaceutica
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-10-20 6:00 AM EDT | WELL Health Technologies Corp.
CardioComm Solutions and CancerCare Manitoba Launch Remote QT/QTc Interval Monitoring Pilot for Breast Cancer Patients
Toronto, Ontario--(Newsfile Corp. - October 19, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company") announces a collaboration with CancerCare Manitoba ("CCMB") on a pilot study evaluating remote electrocardiogram ("ECG") monitoring for potential QT/QTc interval prolongation after patients begin selected breast cancer drug therapies. During the approximately one-year pilot, patients will use CardioComm's HeartCheck™ CardiBeat handheld ECG monitor f
Technologies, Soins de santé et hôpitaux, Santé
2026-10-19 5:00 PM EDT | CardioComm Solutions, Inc.
Richards Group Inc. Announces October 2026 Dividend
Toronto, Ontario--(Newsfile Corp. - October 19, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced today its cash dividend for the month ended October 31, 2026 of Cdn$0.11 per share. This dividend will be to shareholders of record at the close of business on October 30, 2026 and will be payable on November 13, 2026. Shareholders who are non-residents of Canada may be required to pay all withholding taxes payable in respect of any dividends of income by the Company, whether suc
Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques, Pharmaceutique
2026-10-19 11:36 AM EDT | Richards Group Inc.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
King of Prussia, Pennsylvania--(Newsfile Corp. - October 19, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA therapeutic platform, including its lead clinical ca
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-10-19 9:53 AM EDT | Phio Pharmaceuticals Corp.
Discovery Senior Living Acquires Sunshine Retirement Living, Expanding National Operating Platform and Establishing Strategic Pacific Northwest Presence
Bonita Springs, Florida--(Newsfile Corp. - October 19, 2026) - Discovery Senior Living ("Discovery" or "DSL"), the largest and one of the most trusted seniors housing operators in the U.S., is pleased to announce that it has entered into a definitive agreement to acquire Sunshine Retirement Living ("Sunshine"), an established, multi-state seniors housing management company with a longstanding history in seniors housing ownership and operations. Under the terms of the transaction, Discovery wi
Soins de santé et hôpitaux, Immobilier, Logement
2026-10-19 7:59 AM EDT | Discovery Senior Living
Cosmo Announces Positive Phase 2 Study of Rifamycin 1% Topically Acting Gel, Meeting the Primary Endpoint in Distal Ulcerative Colitis and Ulcerative Proctitis
Ad hoc announcement pursuant to Art. 53 LR 46.2% clinical remission with rifamycin 1% topically acting gel vs 14.3% with placebo (p=0.0190). The therapy represents a new non-immune suppressive treatment modality, designed to achieve delivery to the distal colon with a novel liquid to gel delivery system, and a neutral pH. The results suggest that the
Soins de santé et hôpitaux, Santé
2026-10-19 1:09 AM EDT | Cosmo Pharmaceuticals N.V.
NABIP Seeks Injunctive Relief Against HHS and CMS over Marketplace Moratorium Affecting Nearly 19,000 Agents and Brokers
Washington, D.C.--(Newsfile Corp. - October 15, 2026) - The National Association of Benefits and Insurance Professionals (NABIP) today filed suit against the Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS), challenging a new rule and policy that, together, prevent thousands of health insurance agents and brokers from participating in the federally facilitated Affordable Care Act (ACA) Marketplace during the Open Enrollment period beginn
Soins de santé et hôpitaux, Assurances
2026-10-15 4:20 PM EDT | National Association of Benefits and Insurance Professionals (NABIP)
Extendicare Announces October 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - October 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of October 2026, which is payable on November 16, 2026 to shareholders of record at the close of business on October 30, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-10-15 8:00 AM EDT | Extendicare Inc.
HEALWELL AI Named to TIME's World's Top HealthTech Companies of 2026 and Announces 12 Real-World Evidence and Clinical AI Presentations at International Conferences This Fall.
Toronto, Ontario--(Newsfile Corp. - October 15, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQ
Technologies, Soins de santé et hôpitaux
2026-10-15 6:00 AM EDT | HEALWELL AI
medmix Launches MIXPAC(TM) PiccoMix(TM) to Advance Efficiency and Sustainability in Dental Cementation Delivery
Baar, Switzerland--(Newsfile Corp. - October 15, 2026) - medmix introduces the new MIXPAC™ PiccoMix™ mixing tip, a next-generation solution for dental cementation delivery designed to help dental
Technologies, Construction / bâtiments, Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques
2026-10-15 3:08 AM EDT | medmix AG